Famciclovir and Face presentation - a phase IV clinical study of FDA data
We study 2,785 people who take Famciclovir or have Face presentation. No report of Face presentation is found in people who take Famciclovir.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Famciclovir?
Famciclovir has active ingredients of famciclovir. It is often used in herpes zoster. eHealthMe is studying from 2,708 Famciclovir users for its effectiveness, alternative drugs and more.
What is Face Presentation?
Face presentation (presentation of child in uterus) is found to be associated with 61 drugs and 62 conditions by eHealthMe.
Do you take Famciclovir and have Face presentation?Check whether Face presentation is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Famciclovir:
- Famciclovir (2,708 reports)
Face presentation treatments and more:
- Face presentation (77 reports)
COVID vaccines that are related to Face presentation:
- Face presentation in Moderna COVID Vaccine
- Face presentation in Pfizer BioNTech Covid Vaccine
- Face presentation in Johnson and Johnson Covid Vaccine
How severe was Face presentation and when was it recovered:
Expand to all the drugs that have ingredients of famciclovir:
All the drugs that are associated with Face presentation:
All the conditions that are associated with Face presentation:
How the study uses the data?
The study uses data from the FDA. It is based on famciclovir (the active ingredients of Famciclovir) and Famciclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.